BRAX
EURONEXT:BRAX
Braxia Scientific Corp.
- Stock
Last Close
0.01
02/08 18:14
Market Cap
1.42M
Beta: 1.70
PE Ratio
−0.08
PFCF: −0.16
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '20 | Mar '21 | Mar '22 | Mar '23 | ||
|---|---|---|---|---|---|
average inventory | 4.34K - | ||||
average payables | 1.32M - | 1.32M 0% | |||
average receivables | 462.23K - | 462.23K 0% | |||
book value per share | 0.03 - | 0.10 259.03% | 0.05 49.26% | 0.05 0% | |
capex per share | -0.00 - | -0.00 - | -0.00 0% | ||
capex to depreciation | -28.97 - | -1.09 - | -1.09 0% | ||
capex to operating cash flow | 0.21 - | 0.01 - | 0.01 0% | ||
capex to revenue | -283.02 - | -0.02 - | -0.02 0% | ||
cash per share | 0.02 - | 0.07 224.56% | 0.05 29.68% | 0.05 0% | |
days of inventory on hand | 1.35K - | 2.55 - | |||
days payables outstanding | 1.26K - | 835.91 33.42% | 194.34 76.75% | 194.34 0% | |
days sales outstanding | 41.06 - | 199.05 384.76% | 199.05 0% | ||
debt to assets | 0.01 - | 0.02 220.72% | 0.02 0% | ||
debt to equity | 0.01 - | 0.02 257.78% | 0.02 0% | ||
dividend yield | |||||
earnings yield | -0.01 - | -1.19 15,947.37% | -1.15 3.12% | -2.77 140% | |
enterprise value | 22.41M - | 129.31M 476.94% | 2.05M 98.41% | -4.08M 298.60% | |
enterprise value over ebitda | -131.53 - | -12.31 90.64% | -0.30 97.58% | 0.59 298.60% | |
ev to operating cash flow | -77.60 - | -25.57 67.04% | -0.45 98.22% | 0.90 298.60% | |
ev to sales | 105.72K - | 128.23 99.88% | 1.38 98.92% | -2.74 298.60% | |
free cash flow per share | -0.01 - | -0.03 262.62% | -0.03 19.16% | -0.03 0% | |
free cash flow yield | -0.01 - | -0.04 140.39% | -0.43 1,099.07% | -1.04 140.00% | |
graham net net | 0.02 - | 0.05 162.17% | 0.04 30.70% | 0.04 0.07% | |
graham number | 0.05 - | 1.55 2,848.04% | 0.28 81.80% | 0.28 0% | |
income quality | 1.67 - | 0.06 96.60% | 0.37 554.20% | 0.37 0% | |
intangibles to total assets | 0 - | 0.38 Infinity% | 0.15 60.10% | 0.15 0% | |
interest coverage | -3.23K - | -1.40K 56.63% | -1.40K 0% | ||
interest debt per share | 0.00 - | 0.00 80.21% | 0.00 0% | ||
inventory turnover | 0.27 - | 142.94 - | |||
invested capital | 0.01 - | 0.02 257.78% | 0.02 0% | ||
market cap | 23.27M - | 140.30M 502.97% | 10.51M 92.51% | 4.38M 58.33% | |
net current asset value | 989.28K - | 8.80M 789.07% | 6.99M 20.51% | 6.99M 0% | |
net debt to ebitda | 5.02 - | 1.05 79.16% | 1.23 17.08% | 1.23 0% | |
net income per share | -0.00 - | -1.06 24,107.05% | -0.07 93.47% | -0.07 0% | |
operating cash flow per share | -0.01 - | -0.03 337.94% | -0.03 19.61% | -0.03 0% | |
payables turnover | 0.29 - | 0.44 50.19% | 1.88 330.13% | 1.88 0% | |
receivables turnover | 8.89 - | 1.83 79.37% | 1.83 0% | ||
research and ddevelopement to revenue | 235.85 - | 1.96 99.17% | 0.13 93.40% | 0.13 0% | |
return on tangible assets | -0.15 - | -14.60 9,709.99% | -1.23 91.58% | -1.23 0% | |
revenue per share | 0.00 - | 0.01 118,895.32% | 0.01 32.67% | 0.01 0% | |
roe | -0.16 - | -10.52 6,642.42% | -1.35 87.13% | -1.35 0% | |
roic | -0.16 - | 3.48 2,335.28% | 1.08 68.93% | -0.74 168.66% | |
sales general and administrative to revenue | 322.06 - | 6.78 97.89% | 4.65 31.45% | 4.65 0% | |
shareholders equity per share | 0.03 - | 0.10 259.03% | 0.05 49.26% | 0.05 0% | |
stock based compensation to revenue | 15.18K - | 0.22 100.00% | 0.58 - | ||
tangible asset value | 1.11M - | 8.85M 698.93% | 7.19M 18.67% | 7.19M 0% | |
tangible book value per share | 0.03 - | 0.06 99.87% | 0.04 26.84% | 0.04 0% | |
working capital | 989.28K - | 8.84M 793.99% | 7.12M 19.44% | 7.12M 0% |
All numbers in USD (except ratios and percentages)